Integral Health Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100,000
| Closed | -$5.1M | – | 91 |
|
|
2025
Q1 | $5.1M | Buy |
+100,000
| New | +$5.1M | 0.54% | 47 |
|
|
2023
Q3 | – | Sell |
-174,000
| Closed | -$7.08M | – | 85 |
|
|
2023
Q2 | $7.08M | Sell |
174,000
-4,000
| -2% | -$163K | 0.88% | 43 |
|
|
2023
Q1 | $8.62M | Buy |
178,000
+78,000
| +78% | +$3.78M | 1.74% | 24 |
|
|
2022
Q4 | $3.82M | Sell |
100,000
-63,000
| -39% | -$2.4M | 0.8% | 43 |
|
|
2022
Q3 | $8.18M | Buy |
163,000
+58,344
| +56% | +$2.93M | 1.59% | 22 |
|
|
2022
Q2 | $4.19M | Buy |
104,656
+62,656
| +149% | +$2.51M | 0.86% | 40 |
|
|
2022
Q1 | $1.57M | Sell |
42,000
-3,000
| -7% | -$112K | 0.41% | 58 |
|
|
2021
Q4 | $1.79M | Sell |
45,000
-52,100
| -54% | -$2.07M | 0.5% | 56 |
|
|
2021
Q3 | $3.61M | Sell |
97,100
-13,000
| -12% | -$484K | 1.04% | 39 |
|
|
2021
Q2 | $4.65M | Buy |
110,100
+10,000
| +10% | +$423K | 1.28% | 31 |
|
|
2021
Q1 | $4.74M | Buy |
100,100
+70,000
| +233% | +$3.31M | 1.35% | 29 |
|
|
2020
Q4 | $1.84M | Hold |
30,100
| – | – | 0.55% | 47 |
|
|
2020
Q3 | $1.41M | Buy |
30,100
+100
| +0.3% | +$4.67K | 0.43% | 62 |
|
|
2020
Q2 | $1.52M | Buy |
+30,000
| New | +$1.52M | 0.46% | 54 |
|